inception, this series of yearly meetings has continued to emphasize the molecular aspects of toxicity, carcinogenesis, and cancer prevention and the relationships among the three as they relate to human risk.
given by Dr. Tony Hunter, followed by a poster session presented by the Young Investigators. This unique approach to topic presentations of immediate relevance to the scientific community followed by informal discussions has been extremely successful and has fostered development and exchange of ideas, along with considerable collaborations among scientists from academia, industry, and government. The Fifteenth Aspen Cancer Conference Workshop, to be held July [16] [17] [18] 2000 , will include sessions on genomic instability: DNA repair and centrosome fidelity, molecular mechanisms of cellular immortality, cause and prevention of hormonal cancers, regulatory implications of biomarkers of exposure and effect, apoptosis, chemoprevention, microarray technology in toxicology and cancer therapy, PPARs, nuclear export and import, and rational cancer therapy: signalling pathways.
The success and recognition of the Aspen Cancer Conference series, along with its high impact on the scientists of today and the future, continues to be a credit to all who attend and participate formally and informally by the presentation of their ideas. Additionally, none of the above would be possible without the Advisory Committee, which has worked diligently throughout the many years, and without sponsor support. It is to all of these individuals that I give my special thanks and appreciation.
The extended abstracts with references follow. BENJAMIN F. TRUMP, M.D.
